Anti-NKG2A antibodies and uses thereof

Details for Australian Patent Application No. 2007276294 (hide)

Owner Novo Nordisk A/S

Inventors Padkaer, Soren Berg; Spee, Petrus Johannes Louis

Agent Shelston IP

Pub. Number AU-A-2007276294

PCT Pub. Number WO2008/009545

Priority 06116429.9 30.06.06 EP

Filing date 28 June 2007

Wipo publication date 24 January 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/009545 Priority application(s): WO2008/009545

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007276302-Switching device for underwater turbine

2007276289-Process for preparing triallyl cyanurate